This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Cellect Biotherapeutics Ltd., Cellect Biotechnology Ltd., Other. Active years: 2006-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 3 
1 out of 1 
1 out of 834,570 Years Active: 2006-2017
Title: Nadir Askenasy: Innovator in Apoptosis-Resistant Cell Selection
Introduction
Nadir Askenasy is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of immunology, particularly in the selection of apoptosis-resistant cells. With a total of 4 patents to his name, Askenasy's work is paving the way for advancements in therapeutic applications.
Latest Patents
Askenasy's latest patents include innovative devices and methods for selecting apoptosis-signaling resistant cells. One notable patent describes a device and kit designed for the selection of cells resistant to receptor-mediated apoptosis. This device allows for the negative selection of mature immune cells that can induce graft versus host disease (GvHD) from a heterogeneous cell population. The efficiency of this device lies in its ability to simplify the cell selection process using an off-the-shelf product, a solution that is currently unavailable in the market. Another patent focuses on regulatory immune cells with enhanced targeted cell death effects. This patent discloses an isolated immune regulatory cell with an exogenous cell death-inducing moiety attached to its surface, along with methods for generating and utilizing these cells in pharmaceutical compositions.
Career Highlights
Throughout his career, Nadir Askenasy has worked with notable companies such as Cellect Biotherapeutics Ltd. and Cellect Biotechnology Ltd. His experience in these organizations has contributed to his expertise in the field of cell selection and immunotherapy.
Collaborations
Askenasy has collaborated with various professionals in his field, including his coworker Shai Yarkoni. These collaborations have further enhanced his research and development efforts.
Conclusion
Nadir Askenasy is a key figure in the innovation of apoptosis-resistant cell selection technologies. His patents and career achievements reflect his commitment to advancing medical science and improving therapeutic outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile